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Background: Type I collagen is the most abundant organic component in bone, providing form and stability.
Results: Lysyl hydroxylase 3-mediated glucosylation occurs at specific sites in collagen, including cross-linking sites, and
suppression of this modification results in defective collagen and mineralization.
Conclusion: The data indicate the critical importance of this modification in bone physiology.
Significance: Alterations of this collagen modification may cause bone defects.
Recently, by employing the short hairpin RNA technology, we
have generated MC3T3-E1 (MC)-derived clones stably sup-
pressing lysyl hydroxylase 3 (LH3) (short hairpin (Sh) clones)
and demonstrated the LH3 function as glucosyltransferase in
type I collagen (Sricholpech, M., Perdivara, I., Nagaoka, H.,
Yokoyama, M., Tomer, K. B., and Yamauchi, M. (2011) Lysyl
hydroxylase 3 glucosylates galactosylhydroxylysine residues in
type I collagen in osteoblast culture. J. Biol. Chem. 286, 8846–
8856). To further elucidate the biological significance of this
modification, we characterized and compared type I collagen
phenotypes produced by Sh clones and two control groups, MC
and those transfected with empty vector. Mass spectrometric
analysis identified five glycosylation sites in type I collagen (i.e.
1,2-87, 1,2-174, and 2-219. Of these, the predominant gly-
cosylation site was 1-87, one of the major helical cross-linking
sites. In Sh collagen, the abundance of glucosylgalactosylhy-
droxylysine was significantly decreased at all of the five sites
with a concomitant increase in galactosylhydroxylysine at four
of these sites. The collagen cross-links were significantly dimin-
ished in Sh clones, and, for the major cross-link, dihydroxylysi-
nonorleucine (DHLNL), glucosylgalactosyl-DHLNL was dimin-
ished with a concomitant increase in galactosyl-DHLNL.When
subjected to in vitro incubation, in Sh clones, the rate of decrease
in DHLNLwas lower, whereas the rate of increase in its matura-
tional cross-link, pyridinoline, was comparable with controls.
Furthermore, in Sh clones, the mean diameters of collagen
fibrils were significantly larger, and the onset of mineralized
nodule formation was delayed when compared with those of
controls. These results indicate that the LH3-mediated gluco-
sylation occurs at the specific molecular loci in the type I colla-
gen molecule and plays critical roles in controlling collagen
cross-linking, fibrillogenesis, and mineralization.
O-Linked glycosylation of hydroxylysine (Hyl)2 residues
has long been known to be a unique post-translational mod-
ification for collagens and proteins with collagenous
sequences (1–3). This modification is catalyzed by two
groups of collagen glycosyltransferases, hydroxylysine galac-
tosyltransferase (EC 2.4.1.50) and galactosylhydroxylysine glu-
cosyltransferase (EC 2.4.1.66), resulting in the formation of
galactosylhydroxylysine (G-Hyl) and glucosylgalactosylhy-
droxylysine (GG-Hyl), respectively (4). It has been reported
that the hydroxylysine galactosyltransferase activity is cata-
lyzed by the multifunctional enzyme lysyl hydroxylase 3 (LH3)
(5, 6) and the recently identified glycosyltransferase family 25
domains 1 and 2 (GLT25D1 and -D2) (7). The galactosylhy-
droxylysine glucosyltransferase activity, on the other hand, was
found to be mainly catalyzed by LH3 (5, 8–12).
The pattern of collagen glycosylation varies depending on
collagen types (1, 2), functional regions within the same tissue/
same collagen type (13, 14), maturation (15–17), and patholog-
ical conditions (18–25). In bone, type I collagen is relatively less
glycosylated (15, 26, 27); however, in bone/skeletal disorders,
such as osteogenesis imperfecta (20, 28–30), postmenopausal
osteoporosis (19, 23, 31, 32), osteosarcoma, osteofibrous dys-
plasia (21), and Kashin-Beck disease (33), altered collagen gly-
cosylation occurs, and this has been implicated in mineraliza-
tion defects. Due to the structure of the carbohydrates and the
glycosylation sites, structural as well as biological functions
have been proposed for collagen glycosylation (i.e. control of
collagen fibrillogenesis (33–37), cross-linking (38–42), remod-
eling (33), collagen-cell interaction (43, 44), and induction of
vessel-like structures (45)), all of which are important for the
formation of functional fibrils for biomineralization. Despite all
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of the findings regarding collagen glycosylation reported to
date, the precise molecular loci, the extent/type of glycosyla-
tion, and their biological functions are still not clearly defined.
In our recent report (12), by employing the short hairpin (Sh)
RNA technology, we have demonstrated that the major func-
tion of LH3 for type I collagen is to transfer glucose units to
G-Hyl residues and that alteration in the level of glucosylation
significantly affects the kinetics of collagen fibrillogenesis in
vitro. In the present study, by using this system, we identified
the LH3-mediated glucosylation sites in type I collagen and
investigated the potential roles of this modification in type I
collagen phenotypes by analyzing cross-linking pattern and
maturation, fibrillogenesis, and matrix mineralization.
EXPERIMENTAL PROCEDURES
Cell Culture, Generation of Sh Clones, and Purification of
Type I Collagen
The pSilencer2.1-U6/neo-Plod3 construct encoding the
short hairpin sequence targeting Plod3 was generated, and the
MC3T3-E1 (MC) cell-derived clones stably suppressing Plod3
(Sh clones)were obtained as described previously (12).MCcells
and those transfected with the original pSilencer2.1-U6/neo
plasmid (EV; encoding a hairpin siRNA sequence not found in
any genome database) were used as controls. The phenotype of
type I collagen synthesized by three Sh clones (Sh1-1, Sh1-2,
and Sh1-3) and controls were further characterized in this
study.
Identification of Glycosylated Hyl Residues by Mass
Spectrometry
 Chain Separation and Proteolysis—Type I collagen was
purified from MC, EV, and Sh clones as reported (12), and the
1 and 2 chains were separated by SDS-PAGE on 4–12% Bis-
Tris precast gels (Invitrogen) for 1 h at 200 V, 100 mA, and 10
W. Following staining with Coomassie Simply Blue, the protein
bandswere excised and subjected to automated in-gel digestion
with trypsin overnight at 37 °C, using a Progest robot digester
(Genomic Solutions, Harbor, MI). The samples were lyophi-
lized and stored at 80 °C until further use.
Mass Spectrometry—The collagen proteolytic mixtures were
analyzed by LC-MS on a Waters-Micromass Q-Tof Premier
hybrid tandem mass spectrometer equipped with a nano-
Acquity UPLC system (Waters, Milford, MA). The lyophilized
tryptic digests were reconstituted in 30–40 l of 0.1% formic
acid in deionized water. Analyses were performed on a 1.7-m,
100m 100-mm, BEH dC18 column (Waters,Milford,MA),
using a flow rate of 300 nl/min. A C18 trapping column (180
m 20mm) with a 5-mparticle size (Waters, Milford, MA)
was positioned in-line of the analytical column and upstreamof
a micro-tee union used both as a vent for trapping and as a
liquid junction. Trappingwas performed for 3min at a 5l/min
flow rate, using the initial solvent composition.A3-l aliquot of
the digest sample was injected onto the column. Peptides were
eluted by using a linear gradient from 98% solvent A (0.1% for-
mic acid in water (v/v)) and 2% solvent B (0.1% formic acid in
acetonitrile (v/v)) to 40% solvent B over 90 min. Instrument
settings for theMS analysis were as follows: capillary voltage of
3.2 kV, cone voltage of 20 V, collision energy of 6.0 V, and
source temperature of 80 °C. Mass spectra were acquired over
the mass range 200–2000 Da. For calibration, an orthogonal
reference spray (LockSpray) of a solution of Glu1-Fibrinopep-
tide B (500 fmol/l) in water/acetonitrile (80:20, v/v) and 0.1%
formic acid, having a referencemass of 785.8496 (2) was used.
In order to identify glycosylation sites in type I collagen, LC-
tandem mass spectrometry (MS/MS) analyses with data-de-
pendent acquisition of the four most abundant ions was
employed. A collision energy ramp from 30 to 40 V was
employed. To determine the relative levels of Lys, Hyl, G-Hyl,
and GG-Hyl for each observed glycosylation site, triplicate
LC-MS analyses were acquired.
LC-NanoChip-ESI Ion TrapMS—LC-nanoChip-ESI ion trap
MS analyses were performed using an Agilent 6340 XCT Ultra
Ion Trap (Santa Clara, CA) equipped with an HPLCChip Cube
MS interface, an Agilent 1100/1200 nanoHPLC System, and an
electron transfer dissociation module. Ion trap-MS/MS ana-
lyses were performed as follows. 20-l injections of the tryptic
digests dissolved in 0.1% formic acid were loaded onto a 40-nl
enrichment column followed by a 43 mm  75-m analytical
column, packed with ZORBAX 300SB C18 particles (Agilent,
Santa Clara, CA). Linear gradients of 3–50% (0.1% formic acid)
were performed over 50 min at a flow rate of 500 nl/min. The
parameter settings for positive ion ESI-MSwere as follows: cap-
illary voltage, 2000 V; end plate offset, 500 V; capillary exit, 180
V; nebulizer, 2 p.s.i., dry gas, 4 liters/min; dry gas temperature,
325 °C. For MS/MS, electron transfer dissociation (ETD) or
collision-induced dissociation, automated data-dependent
acquisitions of the six most abundant ions were employed. For
collision-induced dissociation, the fragmentation amplitude
was 0.80 V. For ETD analyses, the accumulation time of the
fluoranthene gas was 40ms, and the reaction time was typically
100 or 150 ms.
Data Analysis—The LC-MS/MS and LC-MS data were visu-
alized with the MassLynx software, version 4.1 (Waters, Mil-
ford, MA). Tryptic peptides containing Lys residues and
their hydroxylated and/or glycosylated forms were identified
from the LC-MS/MS analyses of tryptic digests using manual
interpretation of the MS/MS spectra. Relative quantitation
of Lys, Hyl, G-Hyl, and GG-Hyl at a particular glycosylation
site was performed by dividing the total ion abundance
determined for each species by the sum of the ion abun-
dances of all observed species containing that particular site.
For example, the ion abundance for G-Hyl was determined
by summing up the ion abundances determined for each
observed charge state of the multiply protonated glycopep-
tide ion over the chromatographic elution time of the G-Hyl
glycopeptide. For those instances where a modified site was
observed as both enzymatically fully processed and as pep-
tides containing one miscleavage, both species were consid-
ered in the determination of the ion abundance of that mod-
ification. The tryptic peptides and the observed modifica-
tions considered for relative quantitation are summarized in
supplemental Table 1.
Expression of Lysyl Oxidase Family
MC, EV, and Sh clones were plated at a density of 2  105
cells/35-mm dish. After 48 h of culture, total RNA was
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extracted with TRIzol reagent (Invitrogen), and 2 g of total
RNA was converted into cDNA by using the Omniscript
Reverse Transcriptase kit (Qiagen, Valencia, CA). Quantitative
real-time PCR was performed using the sequence-specific
primer for lysyl oxidase (LOX) (Lox; ABI assay number:
Mm00495386_m1), LOXL (Loxl; Mm01145738_m1), LOXL2
(Loxl2;Mm00804740_m1), LOXL3 (Loxl3;Mm00442953_m1),
LOXL4 (Loxl4; Mm00446385_m1). The reactions were pre-
pared and analyzed in triplicates by the ABI Prism 7000
Sequence detection system (Applied Biosystems, Foster city,
CA). ThemRNA expression level of LH3 relative to glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH; ABI assay number
4308313) was analyzed by the 2CT method (46).
Collagen Cross-link Analysis
MC, Sh (Sh1-1, Sh1-2, and Sh1-3) and EV clones were cul-
tured in -minimum essential medium (Invitrogen) containing
10% fetal bovine serum (FBS; Invitrogen) and 50g/ml ascorbic
acid. After 2 weeks of culture, cells/matrices were scraped,
thoroughly washed with phosphate-buffered saline (PBS) and
cold deionized distilled water, and lyophilized. The samples
were prepared for collagen cross-link analysis as described pre-
viously (47). Briefly, 2 mg of dried samples was suspended in
0.15 M N-trismethyl-2-aminoethanesulfonic acid and 0.05 M
Tris-HCl buffer (pH 7.4) and reduced with standardized
NaB3H4. The specific activity ofNaB3H4was determined by the
methodwe reported previously (48). After flushingwithN2, the
reduced samples were hydrolyzed with 6 N HCl in vacuo at
110 °C for 22 h, and then they were dried, dissolved in distilled
water, and filtered. An aliquot of the hydrolysate was subjected
to amino acid analysis to determine hydroxyproline content,
and the hydrolysates with known amounts of hydroxyproline
were analyzed for cross-links on a cation exchange column
(AA-911, Transgenomic, Omaha, NE) linked to a fluorescence
detector (FP1520, Jasco Spectroscopic, Tokyo, Japan) and a
liquid scintillation analyzer (500TR series, Packard Instru-
ment Co., Meriden, CT) as described previously (47). The
cross-link precursor aldehydes (i.e. hydroxylysyl aldehyde
and lysyl aldehyde) and the major reducible cross-links (dehy-
drodihydroxylysinonorleucine/its ketoamine (deH-DHLNL),
dehydrohydroxylysinonorleucine/its ketoamine (deH-HLNL)),
were analyzed as their reduced forms (i.e. dihydroxynorleucine
(DHNL), hydroxynorleucine (HNL), DHLNL, and HLNL,
respectively). Hereafter, the terms DHNL, HNL, DHLNL, and
HLNL will be used for both the unreduced and reduced forms.
The levels of the mature non-reducible cross-links, pyridino-
line (Pyr) and deoxypyridinoline were measured with the fluo-
rescence detector and quantified (47). All cross-links and pre-
cursor aldehydes were quantified as moles per mole of collagen
(48).
Because the O-glycosidic linkage of the carbohydrate
remains intact in base hydrolysis, the glycosylated immature
bifunctional cross-links (GG-DHLNL, G-DHLNL, GG-HLNL,
or G-HLNL) were analyzed by subjecting the reduced cells/
matrices to base hydrolysis with 2 N NaOH as described previ-
ously (42). The pH of the hydrolysate was then adjusted to 3
with 2 N HCl, and filtered. By applying the hydrolysates to the
HPLC system described above, the reducible, glycosylated, and
non-glycosylated cross-links were separated. The glycosylated
cross-links were identified as described previously (49) with
some modifications. Briefly, the base hydrolysates were sub-
jected to partial hydrolysis with 0.2 N and 2 N HCl at 110 °C for
6 h, to stoichiometrically convert the GG- and G- to deglycosy-
lated cross-links, and the respective forms were identified by
HPLC. The glycosylated (GG- and G-) and non-glycosylated
cross-links were quantified as moles/mole of collagen based on
the total values of the cross-links obtained from the acid hydro-
lysates and the ratio of the respective forms obtained from the
base hydrolysates. As for the mature trivalent cross-link, Pyr, a
minor cross-link at 2 weeks of culture, its glycosylated forms
were not quantified because at least 90% of Pyr cross-links were
destroyed by base hydrolysis (50).
In Vitro Collagen Cross-link Maturation Assay
The cell/matrix layers of MC, EV, and Sh clones were col-
lected at 2 weeks of culture, washed, and lyophilized. Several
2-mg aliquots from each group were dispensed in scintilla-
tion vials, suspended in 1 ml of PBS supplemented with 0.7 mM
-aminopropionitrile and two drops of toluene, and sealed.
They were then incubated in the dark at 37 °C. At the end of 2
and 4 weeks of incubation, the samples were removed, reduced
with standardized NaB3H4, hydrolyzed with 6 N HCl, and sub-
jected to cross-link analysis as described above. The non-incu-
bated cell/matrix layers served as the sample at week 0.
Measurements of Collagen Fibril Diameter
MC, EV, and Sh clones were cultured in 35-mm culture
dishes, containing-minimumessentialmedium, 10%FBS, 100
units/ml penicillin, 100g/ml streptomycin, 50g/ml ascorbic
acid, and 2 mM -glycerophosphate, for 2 weeks. The cell/ma-
trix layers were then washed with PBS, fixed with 2.5% EM
grade glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.4.
The sampleswere postfixed in potassium ferrocyanide-reduced
osmium for 1 h, dehydrated with a graded series of ethanol
concentrations, and embedded in PolyBed-812 epoxy resin
(Polysciences, Warrington, PA). Sections of 70 nm were cut,
mounted on copper Formvar-carbon filmed grids, and stained
with 4% uranyl acetate and Reynolds’ lead citrate (51). Cross-
sectional views of the collagen fibrils were observed using a
LEOEM-910 transmission electronmicroscope operating at 80
kV (Carl Zeiss SMT, Peabody, MA), and images were taken at
25,000 using a GatanOrius SC1000 CCD camera with Digital
Micrograph 3.11.0 (Gatan, Inc., Pleasanton, CA). For each sam-
ple, 1200 fibrils were randomly selected, and the diameters
were measured using ImageJ 1.44p software (National Insti-
tutes of Health, Bethesda, MD).
In Vitro Mineralization Assay
MC, EV, and Sh clones were plated at a density of 2  105
cells/35-mm dish and cultured in -minimum essential
medium containing 10% FBS, 100 units/ml penicillin, and 100
g/ml streptomycin. Upon confluence, cells were maintained
in the mineralization medium containing 50 g/ml ascorbic
acid and 2 mM -glycerophosphate and cultured for up to 4
weeks. At the end of each week, the cell/matrix layer from each
sample were washed with PBS, fixed with 100% methanol, and
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stained with 1%Alizarin Red S (Sigma-Aldrich), which binds to
calcium in themineralized nodules deposited (52–54). The rate
and the extent of mineral deposition among the clones with
varying levels of LH3 enzyme were compared. In addition, at 4
weeks of culture, the extent of mineralization was evaluated
from the triplicate measurements of the Alizarin Red S content
by using the method reported previously (55).
Statistical Analyses
Statistical analyses were performed using Jmp8.0 software
(SAS Institute Inc., Cary, NC). Statistical differences were
determined byKruskal-Wallis one-way analysis of variance and
means comparison by Student’s t test. The data were presented
as means  S.D., and a p value less than 0.05 was considered
significant.
RESULTS
Identification of Glycosylation Sites, Form and Extent in
Mouse Type I Collagen, and the Effect of LH3 Suppression—For
glycopeptide analysis, the trypsinized 1 and 2 chains were
analyzed by nanoAcquity UPLC-ESI-QTof Premier MS. Alter-
natively, the tryptic digests were analyzed by HPLC-nanoESI
ion trap equipped with ETD capabilities. The QTof MS and
MS/MS spectra were acquired using data-dependent acquisi-
tion of the four most abundant precursor ions, whereas on the
ion trap, selection of six precursor ions was employed. The
glycopeptides 1(76–90) containing the glycosylated residue
Hyl-87 were observed as triply protonated ions ofm/z 558.949
and 612.971, corresponding to glycoforms of G-Hyl and GG-
Hyl, respectively. The nonhydroxylated Lys was not detected in
this peptide (Table 1), indicating that this residue is quantita-
tively hydroxylated. The extracted ion chromatograms (EIC) of
the two ions in the 1 tryptic digests isolated from theMC and
Sh collagen are shown in Fig. 1. In theMC 1 tryptic digest, the
predominant glycoform was assigned to peptide 76–90 with
residue 87 in the form of GG-Hyl (Fig. 1A) with minimal abun-
dance of the G-Hyl glycoform (Fig. 1B). Structural character-
ization of glycopeptide ions m/z 612.7 (3) and 558.7 (3) by
ETD confirmed the assignment as 1(76–90) containing GG-
Hyl and G-Hyl, based on the presence of fragment ions arising
from cleavage of the N–C bond retaining the glycan moiety
(Fig. 2). In contrast, in the 1 chain isolated from the Sh colla-
gen, the most abundant glycoform at residue 87 was G-Hyl,
whereas GG-Hyl was found with significantly lower relative
abundance compared with MC (Fig. 1, C and D).
In contrast to 1-87, Lys-87 on the 2 chain was foundmod-
ified mainly by Lys hydroxylation in peptide 76–87 (Mr(exp) 
FIGURE 1. Extracted ion chromatograms (EIC) of triply protonated ions of m/z 612.971 and 558.949, corresponding to glycopeptides -1(I)(76 –90),
containing GG-Hyl and G-Hyl, respectively. A and B, MC collagen; C and D, Sh collagen. For each collagen sample, the extracted ion chromatograms were
normalized to the abundance of the most abundant glycoform.
TABLE 1
Summary of specific molecular loci and site occupancy of Lys residue
modifications in purified type I collagen from MC, EV, and Sh clone,








1-87 Lys NDa ND ND
Hyl 1.1  0.9 4.6  0.2 1.5  1.3
G-Hyl 4.2  3.7 60.8  1.2 5.9  1.3
GG-Hyl 94.7  4.6 34.6  1.3 92.6  0.6
1-174 Lys 29.2  1.3 38.0  0.8 34.8  1.1
Hyl 55.4  2.8 51.5  1.0 40.7  0.9
G-Hyl 11.7  1.8 9.6  1.3 11.8  1.2
GG-Hyl 3.7  0.4 0.8  0.4 12.8  0.9
2-87 Lys 4.1  0.3 3.7  0.2 4.6  0.3
Hyl 89.2  0.9 88.3  0.5 84.0  0.5
G-Hyl 0.9  0.2 5.8  0.2 0.8  0.1
GG-Hyl 5.8  0.4 2.1  0.2 10.7  0.2
2-174 Lys 12.1  2.4 7.9  0.7 24.6  0.4
Hyl 9.4  1.4 10.2  0.5 4.8  0.1
G-Hyl 52.7  2.5 75.2  1.2 33.5  0.3
GG-Hyl 25.8  1.5 6.7  0.2 37.1  0.5
2-219 Lys 14  1.4 18.5  1.1 20.6  1.6
Hyl 75.0  5.8 68.1  2.3 52.6  1.7
G-Hyl 3.5  2.3 9.8  1.7 3.7  0.6
GG-Hyl 7.5  4.4 3.5  0.3 23.1  2.6
a ND, not detected.
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1237.578) with minimal amounts of GG-Hyl and G-Hyl (Table
1 and supplemental Table 1 and Fig. 1).
Furthermore, the residues 1-174 and 2-174 were found
modified by various levels of hydroxylation and glycosylation.
In type I collagen isolated from MC, the major modification
observed at residue 1-174, accounting for 55.4% of the site
occupancy, was Lys hydroxylation, whereas glycosylation of
Hyl 174 accounts only for a relatively small amount of modifi-
cation (see Table 1). Within the glycosylated structures, G-Hyl
(Mr(exp)  3576.733, relative abundance 11.7%) was found to be
higher than GG-Hyl (Mr(exp)  3738.823, relative abundance
3.7%). In the collagen purified from the Sh clone, higher relative
amounts of free Lys were found compared with MC (38% in Sh
versus 29.2% in MC), whereas the levels of GG-Hyl in Sh colla-
gen were decreased (0.8% in Sh versus 3.7% inMC). In contrast
to 1-174, higher levels of modification were observed at resi-
due 2-174 (Table 1), because the unmodified Lys accounted
for only 12% of this site. Residue 2-Hyl-174 was found to have
higher levels of glycosylation compared with 1-Hyl-174,
and within the glycosylated forms, G-Hyl (Mr(exp)  4363.177,
relative abundance 52.7%) was higher than that of GG-Hyl
(Mr(exp)  4525.063, relative abundance 25.8%). The identities
of these glycopeptides were confirmed by MS/MS (data not
shown). As a result of the LH3 suppression, higher relative
amounts of G-Hyl and lower amounts of GG-Hyl were identi-
fied at residue 2-174 as well, whereas the relative levels of Lys
and Hyl did not change significantly (see Table 1).
In MC collagen, one additional glycosylation site was identi-
fied at residue 2-219, minimally occupied with GG-Hyl and
G-Hyl, whereas themajormodificationwas assigned toHyl (see
Table 1). It is noteworthy that, unlike residues 1-174 and
2-174, the relative abundance of GG-Hyl (relative abundance
7.5%) was found to be higher than that of G-Hyl (relative abun-
dance 3.5%). The homologous residue 1-219 was largely
observed as Lys or Hyl, whereas no glycosylated structures of
this residue were detected.
FIGURE 2. Structural characterization of 1(I) glycopeptides 76 –90. Shown are ETD spectra acquired on the ion trap of the ions of m/z 612.7 (3) (A) and
m/z 558.7 (3) (B), corresponding to the 1(I) glycopeptides 76 –90 containing GG-Hyl, and G-Hyl, respectively. G, one hexose unit; GG, two hexose units.
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Table 1 summarizes the percentages of site occupancy of
Lys, Hyl, G-Hyl, and GG-Hyl, in type I collagen purified from
MC, Sh, and EV clones, as determined by MS analyses. From
the LC-MS/MS data, peptide heterogeneity might arise from
the following: partial hydroxylation and glycosylation of Lys
and Hyl residues, respectively, partial proline hydroxylation,
methionine oxidation, and trypsin miscleavage at the C ter-
minus to the modified Lys. As expected, trypsin proteolysis
after glycosylated Hyl was completely abolished, as evi-
denced from the observation of glycosylated peptides never
containing G- or GG-Hyl at their C termini. In contrast,
cleavage C-terminal to non-glycosylated Hyl still occurs,
whereas the rate of cleavage appeared to be peptide-specific.
Presumably, the substrate specificity in the Hyl-containing
collagen peptides may be affected by neighboring amino
acids. The peptides and their modifications considered for
the site-specific, relative quantitation of glycosylation are
shown in supplemental Table 1. Collectively, the results
show that in the Sh collagen, the relative abundance of GG-
Hyl is decreased at all of the identified glycosylated sites with
concomitant increases in the levels of G-Hyl. The only
exception was 1-174 where the relative abundance of
G-Hyl did not increase in the Sh clone. The data shown here
are consistent with the previously reported HPLC analysis of
the collagen from MC, EV, and Sh clones (12) and confirm
the function of LH3 as a glucosyltransferase enzyme.
Because the major glucosylation site (1-87) is one of the
major intermolecular cross-linking sites of type I collagen in
mineralized tissues (38, 39, 56–58), its potential effects on
cross-linking were further examined.
Collagen Cross-link Analysis—The collagen cross-links pro-
duced by MC, EV, and Sh clones at 2 weeks of culture were
composed mainly of reducible, immature bifunctional cross-
links, DHLNL and HLNL, and a small amount of mature tri-
functional cross-link (Pyr). Deoxypyridinolinewas not detected
in any of those culture samples. The levels of free precursor
aldehydes, DHNL and HNL, were minimal (0.01 mol/mol of
collagen). The amounts of DHLNL, HLNL, Pyr, and the total
number of aldehydes involved in cross-linking (DHLNL 
HLNL  2 Pyr) are depicted in Table 2. The major immature
cross-link, total DHLNL (GG-, G-, and non-glycosylated
DHLNL), and a mature cross-link, Pyr, in all three LH3-Sh
clones (Sh1-1, -2, and -3) were significantly lower than those of
controls (p  0.05). The total numbers of aldehydes were also
significantly lower in the Sh clones when compared with both
controls (p  0.05). Fig. 3 shows the typical chromatographic
pattern of the base hydrolysates obtained fromMC, Sh, and EV
clones, indicating glycosylated (GG- and G-DHLNL) and non-
glycosylated (DHLNL and HLNL) cross-links. The percentages
of glycosylated (GG- and G-) and non-glycosylated forms of
DHLNL are also indicated. The relative amounts of HLNLwere
unchanged with base hydrolysis, indicating that it is not glyco-
sylated. Approximately one-half of total DHLNL, however, was
found to be glycosylated in all groups. Of the glycosylated
forms, the relative amounts ofGG-DHLNL in all Sh cloneswere
diminished with concomitant increases in G-DHLNL, when
compared with both control groups. The levels of these various
forms of DHLNL were quantified as moles/mole of collagen,
using the total amounts of DHLNL determined from the acid
hydrolysates and their relative ratio, and they are shown in
Table 2. From the Sh clones, there were significant decreases in
the levels of free DHLNL andGG-DHLNL (p 0.05) with con-
comitant increases in the levels of G-DHLNL (p  0.05) when
compared with the controls, MC and EV. In the case of HLNL,
only Sh1-2was significantly lower than that in bothMCandEV,
whereas Sh1-1 and Sh1-3were significantly lower than EVonly.
Expressions of Lysyl Oxidase and Its Isoforms—Because the
amounts of cross-links/total aldehydes were significantly lower
in all Sh clones, we then examined the potential effects of LH3
suppression on the gene expression of LOX, an enzyme respon-
sible for the initiation of cross-linking, and its isoforms (LOXL
and LOXL2 to -4). However, real-time PCR analyses from three
independent experiments showed that the expression of Lox,
Loxl, and Loxl2 to -4 in the Sh clones were essentially identical
to those in the controls, except for the expression of Lox in
Sh1-1, which is comparable withMCbut slightly lower than EV
(p 0.0359) (supplemental Fig. 2). The expression of Loxl2was
not detected in both the controls and Sh clones, thus consistent
with our previous report (59).
In Vitro Cross-link Maturation Assay—It has been proposed
that Pyr is a maturational product from the condensation reac-
tion between two deH-DHLNL/its ketoamine residues (60, 61).
Thus, to assess the potential effect of glycosylation on the cross-
linkmaturation, we have utilized the cell-free in vitro cross-link
maturation assay. This system allows us to directly measure the
amounts of the precursor (deH-DHLNL) and the product (Pyr)
during the incubation period. Fig. 4 shows the changes in the
levels of DHLNL and Pyr over time (weeks 0, 2, and 4).
TABLE 2
Levels of immature reducible cross-links (HLNL, DHLNL, and its glycosylated forms) and mature non-reducible cross-links (Pyr) from MC, EV, and
Sh clones
Values represent mean (S.D. in parentheses) from three independent experiments.
Cells/Clones
Total
DHLNLa GG-DHLNL G-DHLNL DHLNL HLNL Pyr
Total
aldehydesb
mol/mol collagen mol/mol collagen mol/mol collagen mol/mol collagen mol/mol collagen mol/mol collagen mol/mol collagen
MC 1.081 (0.26) 0.480 (0.07) 0.050 (0.02) 0.551 (0.17) 0.210 (0.03) 0.047 (0.008) 1.39 (0.24)
Sh1-1 0.690 (0.07)c 0.223 (0.01)c 0.134 (0.02)c 0.333 (0.04)c 0.170 (0.02)d 0.026 (0.005)c 0.91 (0.07)c
Sh1-2 0.657 (0.03)c 0.171 (0.01)c 0.132 (0.01)c 0.353 (0.01)c 0.155 (0.05)c 0.023 (0.005)c 0.85 (0.01)c
Sh1-3 0.663 (0.08)c 0.200 (0.03)c 0.143 (0.05)c 0.320 (0.01)c 0.169 (0.02)d 0.016 (0.005)c 0.88 (0.10)c
EV 1.056 (0.26) 0.443 (0.09) 0.047 (0.05) 0.565 (0.12) 0.236 (0.01) 0.044 (0.018) 1.38 (0.30)
a Total DHLNL  GG-DHLNL  G-DHLNL  non-glycosylated DHLNL.
b Total aldehydes  total DHLNL  HLNL  2 Pyr.
c Significantly different from both controls MC and EV.
d Significantly different from EV (p  0.05).
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Although the values of the cross-links at week 2 showed some
variation within the groups, those at week 4 were similar to one
another (i.e. for DHLNL, 0.20  0.01 and 0.18  0.02, and for
Pyr, 0.23  0.01 and 0.26  0.04, in controls and Sh clones,
respectively. In Sh clones, on average, DHLNL was diminished
from 0.7  0.04 at week 0 to 0.2  0.02 mol/mol of collagen at
week 4, and Pyr increased from0.03 0.004 at week 0 to 0.26
0.04mol/mol of collagen atweek 4. In controls (MCandEV), on
average, the former decreased from 1.4  0.01 to 0.2  0.02,
and the latter increased from 0.06  0.01 to 0.23  0.01 mol/
mol of collagen. Thus, although the increase of Pyr was compa-
rable between the Sh clones and controls, the rate of decrease in
DHLNL was significantly greater in controls when compared
with that of Sh clones. Three independent incubations were
performed, and the results were reproducible.
Characterization of Collagen Fibrils by Transmission Elec-
tron Microscopy—Cross-sectional views of collagen fibrils and
the diameter distribution obtained from the cultures of Sh
clones (Sh1-1, -2, and -3) and the controls (MC and EV clone)
are shown in Fig. 5. The fibrils from the controls and Sh clones
are generally circular in shape. The fibril diameters were mea-
sured from 1200 randomly selected fibrils of each group. EV
showed a slightly larger mean and range of collagen fibril diam-
eter than those of MC (p  0.05), as seen in the in vitro fibril-
logenesis assay (12). The slight phenotypic difference between
EV and MC, possibly due to the transfection effect, has also
been reported in other studies (52, 54). In all of the Sh clones,
the mean fibril diameters and their ranges were significantly
larger when compared with those of the controls, MC and EV
(p  0.05). The order of the means of fibril diameters from the
smallest to the largest is as follows: MC  EV  Sh1-1  Sh1-
3  Sh1-2. The results shown here are consistent with the tur-
bidity-time curve from the in vitro fibrillogenesis assay, using
purified type I collagen from the Sh clones and the controls (12).
In VitroMatrixMineralization Assay—The results of in vitro
mineralization assay, by Alizarin Red staining, are shown in Fig.
6. In the controls, MC and EV, the formation of mineralized
nodules, was already observed at 2–3weeks of culture and grad-
ually increased in the number and size of the nodules overtime.
On the contrary, matrix mineralization in the Sh clones was
significantly delayed. Sh1-1 and -2 showed almost no nodules
for up to 4 weeks of culture. Sh1-3 showed a few nodules at
week 3, and they increased at week 4 (Fig. 6A). The quantitative
analyses of Alizarin Red S content at week 4 demonstrated that
the extents of mineralization in all Sh clones were significantly
less than those of MC and EV (p  0.05) (Fig. 6B).
DISCUSSION
The glycosylation of type I collagen has been investigated in
the past 45 years, and several molecular loci were identified in
various tissues and species (62–66). However, to the best of our
knowledge, this is the first study to systematically identify the
specific molecular loci and forms of Hyl glycosylation in type I
collagen in any cell culture system. Five specific Hyl residues in
type I collagen were found to be glycosylated, and they are
FIGURE 3. Glycosylation of reducible collagen cross-links obtained from
MC, EV, and Sh clones at 2 weeks of cell culture. The base hydrolysates of
NaB3H4-reduced cells/matrices were analyzed by HPLC. The amounts of GG-,
G-, and DHLNL are shown in percentages (GG-DHLNL  G-DHLNL  DHLNL 
100%). Note the decrease in GG-DHLNL with concomitant increase in
G-DHLNL in the Sh clones, when compared with controls, MC and EV. No
glycosylation was detected for HLNL.
FIGURE 4. In vitro cross-link maturation assay. 2 mg of lyophilized cells/
matrices from MC, EV, and the Sh clones were incubated (for details, see
“Experimental Procedures”). At weeks 2 and 4 of incubation, the samples
were reduced with NaB3H4 and analyzed for the levels of immature reducible
(DHLNL) and mature non-reducible (Pyr) cross-links. The changes in DHLNL
are shown with solid lines, and those of Pyr are shown with dotted lines.
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1-Hyl-87, 1-Hyl-174, 2-Hyl-87, 2-Hyl-174, and 2-Hyl-
219, which is consistent with those previously identified in
other species (62–66). At these sites, the glycosylation pattern
was significantly different between 1 and 2 chains. In the 1
chain, 1-87 was almost fully hydroxylated and glycosylated,
whereas its homologous site on the2 chain contains only trace
amounts of glycosylation. For residue 174, only 15% was gly-
cosylated in the 1 chain, whereas it was nearly 80% in the 2
chain. In addition, bothG- andGG-Hyl formswere identified at
2-219, but none of these was detected at 1-219. The reason
for this differential glycosylation pattern between 1 and 2
chains is not clear at this point. It is of interest to note that the
Hyl residue 2-87 in bovine periodontal ligament (42) and
bovine bone3 type I collagen is mostly glycosylated. By compar-
ing the amino acid sequences of the 1 and 2 chains near the
identified glycosylation sites among different species (e.g.
human mouse, rat, and bovine), it is apparent that in the 1
chain, there is a higher degree of sequence homology around
the Lys residues that were hydroxylated and glycosylated (i.e.
residues 87, 174, and 219 (1 chain: sequence accession num-
bers P02452, P11087, P02454, and P02453, respectively). The
sequence comparison of 2 chain, however, showed some dif-
ferences adjacent to the Lys 87 between the mouse and other
species (GFKGVK versusGFKGIR) but not at residues 174 and
219 (2 chain: sequence accession numbers P08123, Q01149,
P02466, and P02465, respectively). The variation in the amino
acid sequences among the different species probably resulted in
the varied levels of glycosylation between the homologous sites
on 1 and 2 chains, as shown by MS analyses. Collectively,
these results, along with the differences in the amino acid
sequence among the species or the  chains, may implicate
sequence-specific preference for the glycosyltransferase
enzymes.
WhenLH3was suppressed, the levels ofGG-Hylwere greatly
diminished at all of the identified sites with concomitant
3 M. Terajima, I. Perdivara, M. Sricholpech, K. B. Tomer, and M. Yamauchi,
unpublished observations.
FIGURE 5. Ultrastructural analysis of collagen fibrils in cell cultures. The
cells/matrices were collected from MC, EV, and Sh clones after 2 weeks of
culture, and the cross-section of the collagen fibrils was observed under a
transmission electron microscope. The images were taken at a magnification
of 25,000 using Gatan’s Digital Micrograph software. Fibril diameters were
measured using ImageJ 1.44p software, and the diameter distribution was
plotted based on the total number of 1200 fibrils per clone and is shown on
the right.
FIGURE 6. In vitro mineralization assay. A, MC, EV, and Sh clones were cul-
tured in mineralization medium for 1, 2, 3, and 4 weeks. At the end of each
week, the cells/matrices were stained with Alizarin Red S. B, Alizarin Red S
contents of Sh clones and controls. The contents were measured by absorb-
ance at 405 nm at 4 weeks of culture. Error bars, S.D. of triplicate measure-
ments. *, significantly different (p  0.05) from MC and EV. Wk, week.
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increases in G-Hyl at four of the five sites (Table 1). These
results clearly demonstrate that in themouse osteoblast culture
system, 1) glycosylation occurs at specific sites in type I colla-
gen, 2) LH3 functions as glucosyltransferase for all of the iden-
tified sites, and 3) the extent and type of glycosylation vary in a
site-specific manner, but the residue 1-87 appears to be fully
hydroxylated and glycosylated mostly in the form of GG-Hyl.
The distribution of Lys in the 1 and 2 chains, the glycosyla-
tion sites, and relative abundance of the modifications identi-
fied are shown in Fig. 7. Interestingly, all of the glycosylation
sites identified are located in the N-terminal side of the helical
domain of the collagen molecule. The heterogeneity of the
modifications at each site could be attributed to its specific
function in which further investigation is warranted. It is note-
worthy that the most predominant glycosylated site, 1-87, is
one of themajor helical cross-linking sites in type I collagen (56,
57).
There are several unique features of collagen cross-linking in
mineralized tissues that are thought to be important to control
the spatial aspect of mineralization, including the chemical
state of the 1-16C in the C-telopeptide that cross-links to the
juxtaposed helical1/2-87 (48, 56, 57). However, the role of the
glycosylation at the latter residues on cross-linking is not
known. Considering the MS data indicating that the helical
1-87 is almost fully glycosylated and the other helical cross-
linking Hyl (1–930/2–933) are not glycosylated (Table 1; see
“Results”), it is likely that the glycosylated DHLNL is derived
from 1-16C  1-87 (i.e. 2-87 is mostly non-glycosylated).
By applying the tryptic digests of the NaB3H4 reduced cells/
matrices to our standardized column chromatography (42, 56),
we estimated that 80% of the DHLNL cross-link in the cur-
rent cell culture system is derived from1-16C  1/2-87 (data
not shown), which is consistent with the previous data on bone
collagen (56). Some of the non-glycosylated DHLNL could be
derived from 1-16C  2-87 and the N-telopeptide 1-9N/
2-5N  helical1-930/2-933. The precise glycosylation state
of each site needs to be determined by isolation of the peptides
followed by MS analysis. As for HLNL, in both Sh clones and
controls, no significant glycosylation was found. This is proba-
bly due to the fact that the majority of the HLNL cross-link is
derived from hydroxylysyl aldehyde  Lys (67) in mineralized
tissues (thus, no glycosylation).
The data indicated the regulatory roles of LH3-mediated glu-
cosylation in collagen cross-linking. In Sh clones, the levels of
cross-links (both DHLNL and Pyr) were significantly dimin-
ished. Because the gene expression levels of Lox and Loxls in the
Sh clones were comparable with those of controls, the decrease
in cross-links could be due to the impaired activity of LOX. It
has been reported that LOX is more active toward quarter-
staggered, native collagen fibrils, and it has been suggested that
the intermolecular interactions between collagenmolecules are
important for the enzyme activity (68). Studies have also shown
that the binding sites for LOX in type I collagen are in the triple
helical region (69), potentially in the area with highly conserved
sequences (Hyl-Gly-His-Arg, corresponding to the residues
87–90 and 930–933 on  chains), where it can catalyze the
formation of Lys or Hyl aldehyde in the juxtaposed C- or N-
telopeptides of the adjacent collagen molecule (70). Thus, the
decrease in G-Hyl glucosylation at 1-87 of the Sh collagen
could affect the binding and/or activity of the LOX enzymes,
leading to the diminished level of cross-linking.
The LH3-mediated glucosylation could also play a role in the
cross-link maturation. It has been proposed that the bifunc-
tional cross-link, DHLNL, matures into the trifunctional
mature cross-link, Pyr, by condensation between two residues
of DHLNL/ketoamine (60, 61, 71). However, the stoichiometry
between the decrease in DHLNL and the increase in Pyr in a
ratio of 2:1 does not always exist. For instance, Eyre et al. (72)
reported in human bone tissue a fast decrease in the level of
immature bifunctional cross-linkswith age, whereas the level of
Pyr formation was disproportionately lower. In the current
study, the results of an in vitro incubation assay showed that
there was a faster decrease in DHLNL in the controls, MC and
EV, compared with the Sh clones. The decrease of DHLNL in
the former was disproportionately greater than the formation
of its maturational product, Pyr. It is of interest to note that if
the amounts of GG-DHLNL are not accounted for, the ratio of
the decrease of (G-DHLNL  DHLNL) and the increase of Pyr
from week 0 to week 4 was close to 2:1 regardless of the cell
groups. Therefore, it is possible that the diglycosylated form of
DHLNL may not favor the formation of Pyr but may undergo
further unknown modifications. Robins and Bailey (73) also
suggested the potential role of glycosylation in the DHLNL
maturation based on the observation that the rate of disappear-
ance ofDHLNLwas faster than that ofHLNL in vitro. In light of
this, it is notable that several reports had demonstrated the
presence ofG-Pyr and free Pyr but notGG-Pyr in bone collagen
(39, 40, 74). The putative maturation mechanism of DHLNL
into its arginine adduct (75) is less likely in our in vitro incuba-
tion system because no free arginine is available. Further stud-
ies are warranted to elucidate the potential role of glycosylation
(its extent as well as its mono- or diglycosylated forms) in the
FIGURE 7. Molecular loci of glycosylated hydroxylysine residues in 1(I) and 2(I) chains of type I collagen synthesized by MC3T3-E1 cells. Note that the
glycosylated Hyl residues were identified exclusively in the N-terminal helical region of the  chains and that the extent of the modifications varies depending
on the locus. telo, telopeptide; L, lysine; H, hydroxylysine; G, galactosylhydroxylysine; GG, glucosylgalactosylhydroxylysine. Gray squares, lysine or hydroxylysine
residues; black squares, glycosylated hydroxylysine residues.
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DHLNL cross-link maturation. The major collagen cross-link-
ing pathway involving the C-telopeptide (1-16C) and the jux-
taposed helical 1/2-87 residues in the osteoblast culture sys-
tem/mineralized tissues is illustrated in Fig. 8.
The decreased level of LH3-mediated glucosylation also
leads to altered fibrillogenesis, as determined by transmission
electronmicroscopy. The diameters of collagen fibrils from the
Sh clones are significantly larger than those of controls. This
result is in agreement with our previous report (12) and others
(33, 34, 36, 37) showing that collagen with lower levels of gly-
cosylation forms larger diameter fibrils in vitro. On the con-
trary, Risteli et al. (25) have shown that the mean collagen fibril
diameters from the skin of adult heterozygous LH3 knock-out
mice are significantly smaller than those from the wild type
mice. The discrepancy observed may arise from the differences
in cell types (i.e. osteoblasts versus fibroblasts) and their
microenvironment.
In the present study, the Sh clones (collagen with low gluco-
sylation) showed delayed mineralization in vitro. It is not clear
what causes the delay. This could be due to an altered interac-
tion between collagen and non-collagenous proteins important
for the initiation of mineralization (54, 76, 77), which could be
caused by lower levels of GG-Hyl. Based on the molecular loci
of glycosylation identified by MS, the sites are located in close
proximity to or in the gap zone, which is the putative site for the
initiation of mineralization (78, 79). According to the func-
tional and ligand binding regions mapped in type I collagen,
those glycosylation sites are in the binding areas of various
matrix proteins (e.g. integrins, proteoglycans, phosphophoryn,
and discoidin domain receptor 2) (80). Therefore, the glycosy-
lated Hyl residues exclusively in these regions may play a regu-
latory role in the mineralization process either directly by facil-
itating the deposition of minerals or indirectly by interacting
with non-collagenous proteins. Alternatively, defective con-
nectivity of collagenmolecules in the fibril due to the low levels
of cross-links may also delay the process of mineralization (48,
57). Further studies are warranted to elucidate the potential
roles of collagen glycosylation in mineralization.
In conclusion, this study clearly demonstrates that the
LH3-mediated glucosylation occurs at at least five specific
sites in type I collagen, the major one being at 1-87, which
is involved in intermolecular cross-linking. The suppression
of LH3 causes altered cross-link formation, cross-link mat-
uration, fibrillogenesis, and mineralization. These results
underscore the critical roles of this post-translational mod-
ification in collagen functions.
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